UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 16, 2016 9:00 A.M.
Form: S-3
CIK: 0001321834
Company Name: Akers Biosciences Inc
File Number: 333-214214